Research
Open Access
Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
Tyler Pitre, Rebecca Van Alstine, Genevieve Chick, Gareth Leung, David Mikhail, Ellen Cusano, Faran Khalid and Dena Zeraatkar
CMAJ July 25, 2022 194 (28) E969-E980; DOI: https://doi.org/10.1503/cmaj.220471
Tyler Pitre
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
MA MDRebecca Van Alstine
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
MDGenevieve Chick
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
MDGareth Leung
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
MScDavid Mikhail
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
Ellen Cusano
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
MDFaran Khalid
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
BScDena Zeraatkar
Division of Internal Medicine (Pitre), McMaster University, Hamilton, Ont.; Department of Medicine (Pitre, Van Alstine, Chick), Grand River Hospital, Kitchener, Ont.; Michael G. DeGroote School of Medicine (Pitre, Van Alstine, Chick, Khalid), McMaster University, Hamilton, Ont.; Faculty of Medicine (Leung), University of Ottawa, Ottawa, Ont.; Faculty of Health Sciences (Mikhail), McMaster University, Hamilton, Ont.; Division of Hematology and Hematological Malignancies (Cusano), Department of Medicine, University of Calgary, Alta.; Harvard Medical School (Zeraatkar), Harvard University, Boston, Mass.; Health Research Methods, Evidence and Impact, Faculty of Health Sciences (Zeraatkar), McMaster University, Hamilton, Ont.
PhD![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data supplements
Online appendix
Related Articles
- Dawes, M. (2021). Consider patient risk factors for melanoma when prescribing antihypertensives. CMAJ, 193(25), E996. Accessed July 16, 2024. https://doi.org/10.1503/cmaj.78786.
- Hohl, C. M., & McRae, A. D. (2022). Antiviral treatment for COVID-19: ensuring evidence is applicable to current circumstances. CMAJ, 194(28), E996-E997. Accessed July 16, 2024. https://doi.org/10.1503/cmaj.221012.
In this issue
Article tools
Respond to this article
Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
Tyler Pitre, Rebecca Van Alstine, Genevieve Chick, Gareth Leung, David Mikhail, Ellen Cusano, Faran Khalid, Dena Zeraatkar
CMAJ Jul 2022, 194 (28) E969-E980; DOI: 10.1503/cmaj.220471
Jump to section
Related Articles
Cited By...
- Evolution of serious and life-threatening COVID-19 pneumonia as the SARS-CoV-2 pandemic progressed: an observational study of mortality to 60 days after admission to a 15-hospital US health system
- ChatGPT for assessing risk of bias of randomized trials using the RoB 2.0 tool: A methods study
- How do network meta-analyses address intransitivity when assessing certainty of evidence: a systematic survey
- Effectiveness of Nirmatrelvir-Ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies
- Evolution of Life-Threatening COVID-19 as the SARS-CoV-2 Pandemic Has Progressed
- A comparison of the effectiveness of biologic therapies for asthma: a systematic review and network meta-analysis
- Antiviral treatment for COVID-19: ensuring evidence is applicable to current circumstances